[Update on recent progress in vitamin D research. Eldecalcitol and intestinal calcium absorption.]

Area of Science:

• Endocrinology
• Bone Biology
• Nutritional Science

Background:

• Vitamin D is crucial for calcium absorption, which declines with age and decreasing dietary intake in Japan.
• Low calcium absorption rates necessitate interventions to improve intestinal calcium uptake.
• Age-related decline in calcium absorption and intake poses public health challenges.

Purpose of the Study:

• To investigate the mechanism by which eldecalcitol enhances intestinal calcium absorption.
• To compare the effects of eldecalcitol and alfacalcidol on active vitamin D levels.
• To elucidate whether eldecalcitol's effects are mediated by active vitamin D or by the drug itself.

Main Methods:

• Comparative analysis of calcium absorption rates.
• Measurement of systemic active vitamin D [1α,25(OH)₂D] concentrations.
• Assessment of bone resorption markers and bone mineral density.

Main Results:

• Eldecalcitol increases intestinal calcium absorption, suppresses bone resorption, and improves bone mineral density.
• Eldecalcitol use results in lower systemic active vitamin D [1α,25(OH)₂D] concentrations compared to alfacalcidol.
• Eldecalcitol inhibits vitamin D activation in the kidney.

Conclusions:

• Eldecalcitol's calcium absorption-boosting effect is presumed to be a direct action of the drug, not mediated by active vitamin D.
• Eldecalcitol offers a potential therapeutic strategy for improving calcium absorption and bone health.
• The findings suggest a novel mechanism for vitamin D analogs in managing calcium homeostasis and bone metabolism.